Article thumbnail

Increasing tumoral 5-fluorouracil concentrations during a 5-day continuous infusion: a microdialysis study

By Inge R. H. M. Konings, Stefan Sleijfer, Ron H. J. Mathijssen, Peter de Bruijn, Inge M. Ghobadi Moghaddam-Helmantel, Linda M. van Dam, Erik A. C. Wiemer, Jaap Verweij and Walter J. Loos
Topics: Original Article
Publisher: Springer-Verlag
OAI identifier: oai:pubmedcentral.nih.gov:3082021
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (1994). Association of intratumor pharmacokinetics of Xuorouracil with clinical response.
  2. (2007). Plasma, tumor, and tissue disposition disposition of STEALTH liposomal CKD602 (S-CKD602) and nonliposomal CKD-602 in mice bearing A375 human melanoma xenografts.
  3. (1999). Relationship between tumor extracellular Xuid exposure to topotecan and tumor response in human neuroblastoma xenograft and cell lines.
  4. (2002). Science, medicine, and the future: microdialysis.
  5. (2007). Tannock IF
  6. (2008). Tumor, tissue and plasma pharmacokinetic studies and antitumor response studies of docetaxel in combination with 9-nitrocamptothecin in mice bearing SKOV-3 human ovarian xenografts.